KALARIS THERAPEUTICS INC
Q1 2026 13F Holders
Symbol
KLRS
CUSIP
482929106
Type
Equity
Class
COM
Num filings
59
Total reported value, excl. options
$108 M
Compare 2026 Q1 to
2026 Q2
2025 Q4
2025 Q3
2025 Q2
2025 Q1
Manager
Report Date
Value ($000)
Shares
Option Type